A randomized, phase III study of sacituzumab govitecan versus treatment of the physician's choice in patients with endometrial cancer after platinum-based chemotherapy and immunotherapy: the ASCENT-GYN-01 study (GOG-3104/ENGOT-en26/APGOT-EN2).

Ramez N. Eskander & Nicoletta Colombo et al. · 2025

Links
Authors
Ramez N. Eskander, Bradley Corr, David Cibula, David S.P. Tan, Noelle Cloven, Eva Guerra, Kosei Hasegawa, Tashanna Myers, Benoit You, Vicky Makker, Flora Zagouri, Lilian T. Gien, Michele Bartoletti, Adrianne Mallen, Linn Woelber, Simonetta Mocci, Kimberly Komatsubara, Long Ma, Nicoletta Colombo